Pliant Therapeutics, Inc. Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Pliant Therapeutics, Inc. (“Pliant Therapeutics, Inc.” or “the Company”) (NASDAQ:PLRX) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Pliant Therapeutics, Inc. investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. I ...